Across TCGA patient cohorts, RPL26P20 RNA expression is significantly associated with the protein abundance of many other proteins, with 6,132 significant associations in total. CCRCC shows the largest number of these associations.

The most reproducible RPL26P20-associated proteins across cancer lineages are PLXND1, SHROOM4_S282, and MRPL35. Each is linked with RPL26P20 in more than 2 cancer types. Because this analysis shows association rather than direction, both RPL26P20-to-partner and partner-to-RPL26P20 results are reported.

Each partner links to its own Q-omics profile.

RNA expression associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (RPL26P20→partner) and Y-score (partner→RPL26P20) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner protein	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
OV	PLXND1 →	+0.325	+0.166	.004	.005	3	3
LSCC	SHROOM4_S282 →	+0.739	+0.218	<.001	.001	3	3
LSCC	MRPL35 →	-0.427	-0.275	<.001	<.001	3	3
COAD	MRPS7 →	-0.361	-0.057	.007	.005	3	3
CCRCC	TBL2 →	-0.296	-0.384	.001	<.001	3	3
LSCC	LSG1 →	-0.482	-0.247	<.001	<.001	3	3

Each partner links to its Q-omics profile. Showing the 6 strongest of 6,132 associations by consensus.

Exploration

RPL26P20 survival (RNA) · tumor vs normal (RNA) · all RPL26P20 data types